Drug profile

The FDA adverse-event record for Clopidogrel 18.75 Mg

Name: Clopidogrel 18.75 Mg - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

10 FDA reports name Clopidogrel 18.75 Mg, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2557 of 2,679
by report volume (all drugs): 10
adverse-event reports: 0.0%
death-coded share: Cat
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Clopidogrel 18.75 Mg ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #2536
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Signature read: 10 reports place Clopidogrel 18.75 Mg in the lower third of FDA AER volume (#2557 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death-coded share of reports

Active Ingredients

Clopidogrel 18.75 Mg

Administration Routes

Oral

Species Affected

Cat 10

Most Affected Breeds

Domestic Shorthair 10

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 2

Chronic kidney disease 2

Vomiting 2

Diarrhoea 1

Respiratory signs 1

Hypokalaemia 1

Anorexia 1

Cough 1

Weight loss 1

Circulatory shock 1

Wheezing 1

Pulmonary oedema 1

Outcome Breakdown

Outcome Unknown

7 (70.0%)

Recovered/Normal

3 (30.0%)

Clopidogrel 18.75 Mg: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Clopidogrel 18.75 Mg (#2557 of 2,679 by report volume); death-coded 0.0%. PlainBreed drug row · report volume stamp 10 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →